VanEck Genomics and Healthcare Innovators UCITS ETF A ISIN IE000B9PQW54, WKN A3DSGJ

 
Add to portfolio Watch Compare
 
 
 
 

Current quote and strategy of VanEck Genomics and Healthcare Innovators UCITS ETF A

Quote
EUR 19.04
XETRA
01.06.23
18.68 52 weeks low/high 21.50
52 weeks low/high
Savings plan ready
Show all offers
 
Investment strategy

The VanEck Genomics and Healthcare Innovators UCITS ETF A seeks to track the MVIS Global Future Healthcare ESG index. The MVIS Global Future Healthcare ESG index tracks companies worldwide that are active in the genomics or e-healthcare industries. The stocks included are filtered according to ESG criteria (environmental, social and corporate governance).

 

MVIS Global Future Healthcare ESG (1)

Equity (1581) World (461) Health Care (23) Innovation (13)
 
Beta Try our new version of the ETF Profile now!   Try now!  

Risk and fees of VanEck Genomics and Healthcare Innovators UCITS ETF A

Risk
EUR 6 m
Fund size
Fund size category

Replication

Physical (Full replication)
Legal structure ETF
Strategy risk Long-only
Fund currency USD

Currency risk

Currency unhedged
Volatility 1 year (in EUR) - -
Inception/ Listing Date 2 September 2022
Fees
0.35% p.a.
Total expense ratio
0.04% Compare 1.38%
Compare ( Equity )
Dividend/ Taxes
Distribution policy Accumulating
Distribution frequency -
Fund domicile Ireland
Tax data Bundesanzeiger
Legal structure
Fund Structure Open-ended Investment Company (OEIC)
UCITS compliance Yes
Fund Provider VanEck
Administrator State Street Custodial Services (Ireland) Limited
Investment Advisor VanEck Asset Management B.V.
Custodian Bank State Street Custodial Services (Ireland) Limited
Revision Company KPMG Ireland
Fiscal Year End 31 December
Swiss representative FIRST INDEPENDENT FUND SERVICES AG
Swiss paying agent Helvetische Bank AG
Tax Status
Germany 30% tax rebate
Switzerland ESTV Reporting
Austria Non-Tax Reporting Fund
UK No UK Reporting
Replication, swap, securities lending
Indextype Total return index
Swap counterparty -
Collateral manager
Securities lending No
Securities lending counterparty
 
 
 

Performance of VanEck Genomics and Healthcare Innovators UCITS ETF A

Loading...
 
 

Savings plan offers for the VanEck Genomics and Healthcare Innovators UCITS ETF A

Select your savings amount:

 
Broker Rating Savings plan offer Brokerage fee More information
free of charge
free of charge
More info
free of charge
free of charge
More info
free of charge
free of charge
More info
EUR 1.50
1.50%
free of charge
More info
 
 

Exposure

Below you find information about the composition of the VanEck Genomics and Healthcare Innovators UCITS ETF A.

Top 10 Holdings
Weight of top 10 holdings
out of 55
59.49%
VERTEX PHARMACEUTICALS ORD
8.51%
REGENERON PHARMACEUTICALS INC
8.49%
MODERNA INC
7.29%
ILLUMINA INC
6.46%
DEXCOM INC
6.45%
VEEVA SYSTEMS INC -A
5.64%
ALNYLAM PHARMACEUTICALS ORD
4.56%
BIONTECH SE ADR
4.55%
INSULET ORD
3.94%
SAREPTA THERAPEUTICS INC DE
3.60%
Countries
United States
77.54%
Germany
5.36%
China
4.39%
Netherlands
3.51%
Other
9.20%
Show more
Sectors
Other
100.00%
As of 31/03/2023
 
 

Description of VanEck Genomics and Healthcare Innovators UCITS ETF A

The VanEck Genomics and Healthcare Innovators UCITS ETF A invests in stocks with focus Innovation, Social/Environmental, Health Care, World. The dividends in the fund are reinvested (accumulating).

The total expense ratio amounts to 0.35% p.a.. The fund replicates the performance of the underlying index by buying all the index constituents (full replication). The VanEck Genomics and Healthcare Innovators UCITS ETF A is a very small ETF with 6m Euro assets under management. The ETF is younger than 1 year and is domiciled in Ireland.
 

Look for similar ETFs

 
 

Returns of VanEck Genomics and Healthcare Innovators UCITS ETF A

Returns in years
Loading...
Returns in periods
Loading...
 
Monthly returns in a heat map
Loading...
 
 

Listings of VanEck Genomics and Healthcare Innovators UCITS ETF A

Loading...
 

Rolling 1 year volatility of VanEck Genomics and Healthcare Innovators UCITS ETF A

Loading...
 
Volatility 1 year Volatility 3 years Volatility 5 years
- - -
Return per risk 1 years Return per risk 3 years Return per risk 5 years
- - -
 

Frequently asked questions

What is the name of CURE?

The name of CURE is VanEck Genomics and Healthcare Innovators UCITS ETF A.

What is the ticker of VanEck Genomics and Healthcare Innovators UCITS ETF A?

The primary ticker of VanEck Genomics and Healthcare Innovators UCITS ETF A is CURE.

What is the ISIN of VanEck Genomics and Healthcare Innovators UCITS ETF A?

The ISIN of VanEck Genomics and Healthcare Innovators UCITS ETF A is IE000B9PQW54.

What are the costs of VanEck Genomics and Healthcare Innovators UCITS ETF A?

The total expense ratio (TER) of VanEck Genomics and Healthcare Innovators UCITS ETF A amounts to 0.35% p.a.. These costs are withdrawn continuously from the fund assets and already included in the performance of the ETF. You don't have to pay them separately. Please have a look at our article for more information about the cost of ETFs.

Is VanEck Genomics and Healthcare Innovators UCITS ETF A paying dividends?

VanEck Genomics and Healthcare Innovators UCITS ETF A is an accumulating ETF. This means that dividends are not distributed to investors. Instead, dividends are reinvested in the fund on the ex-date, which leads to an increase of the ETF's share price.

What's the fund size of VanEck Genomics and Healthcare Innovators UCITS ETF A?

The fund size of VanEck Genomics and Healthcare Innovators UCITS ETF A is 6m Euro. See the following article for more information about the size of ETFs.

Track your ETF strategies online

 
— Data provided by Trackinsight, etfinfo, Xignite Inc. and justETF GmbH.

All quotes are 15 minutes delayed stock exchange quotes or NAVs (=daily published by fund provider). Returns include dividend payments. There is no warranty for completeness, accuracy and correctness for the displayed information.